newsfilter
← Latest News
GlobeNewswire·

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

SCLXSCLXW
  • Scilex Holding Company (NASDAQ: SCLX) signed a binding term sheet with iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.
  • iHolding will purchase $100,000,000 of newly issued Scilex common stock at an expected price of $15.00 per share, totaling approximately 6,666,667 shares.
  • Proceeds from the investment will support strategic growth, including healthcare expansion, product development, acquisitions, working capital, & intellectual property expansion.
  • The transaction remains subject to customary due diligence, definitive agreements, board approvals, stockholder approval, & regulatory clearances.
  • iHolding views the investment as a strategic milestone to enhance Kazakhstan's position as a regional hub for pharmaceutical manufacturing, research, & biotechnology.
  • The deal represents one of the largest Kazakhstan-origin healthcare investments in a U.S.-listed biopharmaceutical company in recent years.
  • Scilex currently markets ZTlido®, ELYXYB®, & Gloperba® while developing pipeline candidates SP-102, SP-103, & SP-104 for various pain & neurodegenerative conditions.